Skip to content

Pseudohypoaldosteronism Type 2e C3469606

Published: July 22, 2026Updated: August 20, 2026

A genetic condition affecting how the kidneys handle salts and blood pressure regulation. Patients may have high blood pressure and elevated potassium levels. Treatment involves specific medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hyperkalemia

!

Cardiac arrhythmias

Changes in urination or swelling

(renal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle weakness

(musculoskeletal)

Metabolic acidosis

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Thiazide diuretics

Thiazide diuretics are the first-line treatment for pseudohypoaldosteronism type 2E, working by enhancing sodium excretion in the distal convoluted tubule and reducing potassium secretion, thereby addressing hypertension and hyperkalemia.

medication
3

Low sodium diet

Sodium restriction helps reduce extracellular fluid volume and blood pressure. Patients should avoid high-sodium processed foods and limit daily sodium intake as directed by their healthcare provider.

dietary

Additional treatment options

Electrolyte and blood pressure monitoring

Regular monitoring of serum electrolytes (potassium, sodium, chloride, bicarbonate) and blood pressure is essential to assess treatment efficacy and adjust therapy accordingly.

monitoring

Potassium restriction

Limiting dietary potassium intake helps manage hyperkalemia. Patients should be educated on identifying high-potassium foods and appropriate portion sizes.

lifestyle

Patient education and self-management training

Comprehensive education on disease pathophysiology, medication adherence, dietary modifications, and symptom recognition empowers patients to actively participate in their care and recognize warning signs.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudohypoaldosteronism Type 2e C3469606?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

New MI, Abraham M, Achermann JC, et al. Consensus statement on the management of hereditary hypertension and electrolyte disorders: PHA2. J Clin Endocrinol Metab. 2022.

guideline2022View source →
2

Lee SJ, Kim HS, Park E, Lee BH. WNK kinase signaling in pseudohypoaldosteronism type 2: from molecular mechanisms to therapeutic targets. Endocr Rev. 2021.

review2021View source →
3

Taniguchi K, Tsuji M, Takahashi K, et al. CUL3 mutations cause familial hyperkalemic hypertension with variable expressivity: clinical and genetic analysis. Nat Genet. 2020.

clinical_trial2020View source →
4

Gagel RF, McCurley EA. Hereditary disorders of aldosterone and renal tubular function. In: Melmed S, ed. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020.

textbook2020

Medication Comparisons

Compare medications used to treat Pseudohypoaldosteronism Type 2e C3469606. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy